Latest News

A selection of recent news and views from Catapult Ventures follows...

Rinicare confirms first European evaluation of its AI falls prevention technology

Manchester-based MedTech start-up Rinicare is working with Odense University Hospital in Denmark on a product evaluation of its unique falls reduction technology solution, SAFE. The Odense University Hospital team will evaluate the extent to whic...

Channel 4 Ventures invests in Maxwellia to support the launch of Lovima®

Maxwellia announces a major investment from Channel 4 Ventures, striking an airtime-for-equity arrangement. The new investment will support the marketing campaign for Lovima®, helping fund a hugely impactful, innovative and educational 36...

Maxwellia announces appointment of Sara Al-Attbi as Medical Affairs Pharmacist

Maxwellia, the UK’s only company 100% dedicated to switching Rx to OTC medicines, has appointed Sara Al-Attbi to the newly created role of Medical Affairs Pharmacist. The role reflects Maxwellia’s focus on and commitment to widening ac...

Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease

21 September 2021: Piscataway, New Jersey; Oxford and Manchester, UK; Mahwah, New Jersey.  Today, Infinity BiologiX, LLC (IBX), Cytox Ltd, and Vanguard Pharma announce the launch of the IBX Alzheimer’s Risk Test, powered by ge...

New study launched to investigate targeted treatments for Schizophrenia

Monument Therapeutics, in collaboration with the University of Nottingham, has announced a preclinical study to support the use of their non-invasive biomarker for cognitive impairment in schizophrenia.  Currently, there are no treatments on...

From our portfolio



CroBio is an agricultural biotechnology start-up specialising in genetically engineered microbes....

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200